These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19896714)

  • 1. Effect of FMD vaccine antigen payload on protection, sub-clinical infection and persistence following needle challenge in sheep.
    Madhanmohan M; Nagendrakumar SB; Narasu ML; Srinivasan VA
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e7-13. PubMed ID: 19896714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep.
    Madhanmohan M; Nagendrakumar SB; Kumar R; Anilkumar J; Manikumar K; Yuvaraj S; Srinivasan VA
    Res Vet Sci; 2012 Oct; 93(2):1050-9. PubMed ID: 22079173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Paton DJ; Barnett PV
    Vaccine; 2005 Jan; 23(9):1106-13. PubMed ID: 15629353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.
    Barnett PV; Keel P; Reid S; Armstrong RM; Statham RJ; Voyce C; Aggarwal N; Cox SJ
    Vaccine; 2004 Mar; 22(9-10):1221-32. PubMed ID: 15003651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
    Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle.
    Moonen P; Jacobs L; Crienen A; Dekker A
    Vet Microbiol; 2004 Nov; 103(3-4):151-60. PubMed ID: 15504586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
    Niedbalski W
    Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NSP immune response of vaccinated animals after in-field exposure to FMDV.
    Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M
    Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
    Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
    Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against foot and mouth disease reduces virus transmission in groups of calves.
    Orsel K; Dekker A; Bouma A; Stegeman JA; de Jong MC
    Vaccine; 2005 Sep; 23(41):4887-94. PubMed ID: 16002192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J; Zhang Z; Bittner H; Hole K; Singanallur NB; Alexandersen S; Vosloo W
    Vaccine; 2015 Jan; 33(3):422-9. PubMed ID: 25483241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.